|
1
|
Tefferi A and Vardiman JW: Myelodysplastic
syndromes. N Engl J Med. 361:1872–1885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vardiman JW, Thiele J, Arber DA, Brunning
RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM,
Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008
revision of the World Health Organization (WHO) classification of
myeloid neoplasms and acute leukemia: Rationale and important
changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nolte F and Hofmann WK: Myelodysplastic
syndromes: Molecular pathogenesis and genomic changes. Ann Hematol.
87:777–795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aggerholm A, Holm MS, Guldberg P, Olesen
LH and Hokland P: Promoter hypermethylation of p15INK4B, HIC1,
CDH1, and ER is frequent in myelodysplastic syndrome and predicts
poor prognosis in early-stage patients. Eur J Haematol. 76:23–32.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Figueroa ME, Skrabanek L, Li Y, Jiemjit A,
Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway
H, et al: MDS and secondary AML display unique patterns and
abundance of aberrant DNA methylation. Blood. 114:3448–3458. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silverman LR, Demakos EP, Peterson BL,
Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D,
Powell BL, DeCastro CM, et al: Randomized controlled trial of
azacitidine in patients with the myelodysplastic syndrome: A study
of the cancer and leukemia group B. J Clin Oncol. 20:2429–2440.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Z, Chen J, Ford BN, Brackley ME and
Glickman BW: Human DNA repair systems: An overview. Environ Mol
Mutagen. 33:3–20. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bellacosa A: Functional interactions and
signaling properties of mammalian DNA mismatch repair proteins.
Cell Death and Differentiation. 8:1076–1092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fishel R, Lescoe MK, Rao MR, Copeland NG,
Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene
homolog MSH2 and its association with hereditary nonpolyposis colon
cancer. Cell. 75:1027–1038. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peltomäki P: DNA mismatch repair and
cancer. Mutat Res. 488:77–85. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greenberg PL, Tuechler H, Schanz J, Sanz
G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus
F, et al: Revised international prognostic scoring system for
myelodysplastic Syndromes. Blood. 120:2454–2465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Czepulkowski B, Bhatt B, et al: Basic
techniques for the preparation and analysis of chromosomes from
bone marrow and leukaemic bloodHuman cytogenetics: Malignancy and
acquired abnormalities. 3rd. Oxford: Oxford University Press; pp.
1–26. 2001
|
|
14
|
Simons A, Shaffer LG and Hastings RJ:
Cytogenetic Nomenclature: Changes in the ISCN 2013 compared to the
2009 edition. Cytogenet Genome Res. 141:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crescenzi B, La Starza R, Romoli S, Beacci
D, Matteucci C, Barba G, Aventin A, Marynen P, Ciolli S, Nozzoli C,
et al: Submicroscopic deletions in 5q-associated malignancies.
Haematologica. 89:281–285. 2004.PubMed/NCBI
|
|
16
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA. 93:pp.
9821–9826. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Herman JG, Umar A, Polyak K, Graff JR,
Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW,
et al: Incidence and functional consequences of hMLH1 promoter
hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA.
95:pp. 6870–6875. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoang JM, Cottu PH, Thuille B, Salmon RJ,
Thomas G and Hamelin R: BAT-26, an indicator of the replication
error phenotype in colorectal cancers and cell lines. Cancer Res.
57:300–303. 1997.PubMed/NCBI
|
|
19
|
Xu L, Liu C, Chang Y, Liang L, Liu J, Gao
G and Han Q: Theory and method of double-standard curves method of
relative quantification PCR. Biotechnol Bulletin. 1:70–75.
2011.
|
|
20
|
Boland CR and Goel A: The silence of the
genes: Matching mismatch repair defects with tumors. Cancer.
98:2091–2094. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheikhha MH, Tobal K and Liu Yin JA: High
level of microsatellite instability but not hypermethylation of
mismatch repair genes in therapy-related and secondary acute
myeloid leukaemia and myelodysplastic syndrome. Br J Haematol.
117:359–365. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krichevsky S, Siegfried F, Asimakopoulos
FA, Shteper PJ, Goldschmidt N, Rachmilewitz EA, Rund D and
Ben-Yehuda D: Methylation of the promoter regions of DNA repair and
genotoxic stress response genes in therapy-related but not primary
leukemia. Blood. 94:594a1999.
|
|
23
|
Lu BJ, Lai MD, Huang Q and Sheng HQ:
Germline polymorphisms of Bat26 and its significance in gastric
cancer microsatellite instability. Zhejiang Da Xue Xue Bao Yi Xue
Ban. 34:353–357. 2005.(In Chinese). PubMed/NCBI
|
|
24
|
Carethers JM, Hawn MI, Chauhan DP, Luce
MC, Mama G, Koi M and Boland CR: Competency in mismatch repair
prohibits clonal expansion of cancer cells treated with
N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest. 98:199–206.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang H, Richards B, Wilson T, Lloyd M,
Cranston A, Thorburn A, Fishel R and Meuth M: Apoptosis induced by
overexpression of hMSH2 or hMLH1. Cancer Res. 59:3021–3027.
1999.PubMed/NCBI
|
|
26
|
Zhu YM, Das-Gupta EP and Russell NH:
Microsatellite instability and p53 mutations are associated with
abnormal expression of the MSH2 gene in adult acute leukemia.
Blood. 94:733–740. 1999.PubMed/NCBI
|
|
27
|
Austin HS: Etica y psiconanálisis. Br J
Haematol. 111:650–655. 2004.
|
|
28
|
Maeck L, Kohaus P, Haase D, Hiddemann W
and Alves F: Differential cellular expression of the human MSH2
protein in normal and myelodysplastic haematopoiesis. Br J
Haematol. 111:650–655. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen L, Kantarjian H, Guo Y, Lin E, Shan
J, Huang X, Berry D, Ahmed S, Zhu W, Pierce S, et al: DNA
methylation predicts survival and response to therapy in patients
with myelodysplastic syndromes. J Clin Oncol. 28:605–613. 2010.
View Article : Google Scholar : PubMed/NCBI
|
